Feds' Rebate Switch May Cost Mallinckrodt $600M, Suit Says

By Adam Lidgett (May 21, 2019, 7:47 PM EDT) -- Mallinckrodt slapped the Centers for Medicare and Medicaid Services with a lawsuit claiming the agency's push to force the pharma giant to change the formula dictating how much it owes in Medicaid rebates for hormone drug Acthar violates the company's due process rights and could cost it as much as $600 million in back rebates....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!